Elevated soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients.

Lippi, Giuseppe; Henry, Brandon M; Favaloro, Emmanuel J

Lippi, Giuseppe; Henry, Brandon M; Favaloro, Emmanuel J.

Lippi G; Section of Clinical Biochemistry, University of Verona, Verona, Italy.
Henry BM; Cardiac Intensive Care Unit, The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Favaloro EJ; Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), NSW Health Pathology, Westmead Hospital, Westmead, NSW, Australia.

Clin Chem Lab Med ; 59(11): e413-e415, 2021 10 26.

Article in English | MEDLINE | ID: covidwho-1266564

Subject(s)

Biomarkers/metabolism; COVID-19/metabolism; Receptors, Urokinase Plasminogen Activator/metabolism; SARS-CoV-2/metabolism; Adult; Aged; Aged, 80 and over; Biomarkers/blood; COVID-19/diagnosis; Coronavirus Infections/complications; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Oxidative Stress; Prospective Studies; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator/blood; Signal Transduction

Keywords

COVID-19; coronavirus; soluble urokinase plasminogen activator receptor; suPAR

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Biomarkers / Receptors, Urokinase Plasminogen Activator / SARS-CoV-2 / COVID-19 Type of study: Cohort study / Diagnostic study / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: Clin Chem Lab Med Journal subject: Chemistry, Clinical / Laboratory Techniques and procedures Year: 2021 Document Type: Article Affiliation country: Cclm-2021-0561

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google